GreenLight Biosciences Holdings, PBC Quarterly Income Tax Expense (Benefit) in USD for Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
GreenLight Biosciences Holdings, PBC annual/quarterly Income Tax Expense (Benefit) history and growth rate for Q3 2022.
  • GreenLight Biosciences Holdings, PBC Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $1.09M.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.09M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.